MetaVia is trading at $1.49, up +7.19% in live trading on October 23, 2026, with no clear catalyst identified.
- MetaVia’s investor-relations page lists its latest release as the October 13 appointment of a chief medical officer, with no newer announcement shown.
- Major indexes were lower, so broad-market sentiment does not clearly explain the gain.
- Trading volume information was unavailable.